molecular function |
| GO:0042056 | | chemoattractant activity | | Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal. |
| GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| GO:0005126 | | cytokine receptor binding | | Interacting selectively and non-covalently with a cytokine receptor. |
| GO:0004167 | | dopachrome isomerase activity | | Catalysis of the reaction: L-dopachrome = 5,6-dihydroxyindole-2-carboxylate. |
| GO:0016853 | | isomerase activity | | Catalysis of the geometric or structural changes within one molecule. Isomerase is the systematic name for any enzyme of EC class 5. |
| GO:0050178 | | phenylpyruvate tautomerase activity | | Catalysis of the reaction: keto-phenylpyruvate = enol-phenylpyruvate. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0005102 | | receptor binding | | Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
biological process |
| GO:0030330 | | DNA damage response, signal transduction by p53 class mediator | | A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage. |
| GO:0019752 | | carboxylic acid metabolic process | | The chemical reactions and pathways involving carboxylic acids, any organic acid containing one or more carboxyl (COOH) groups or anions (COO-). |
| GO:0007569 | | cell aging | | An aging process that has as participant a cell after a cell has stopped dividing. Cell aging may occur when a cell has temporarily stopped dividing through cell cycle arrest (GO:0007050) or when a cell has permanently stopped dividing, in which case it is undergoing cellular senescence (GO:0090398). May precede cell death (GO:0008219) and succeed cell maturation (GO:0048469). |
| GO:0008283 | | cell proliferation | | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| GO:0007166 | | cell surface receptor signaling pathway | | A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| GO:0045087 | | innate immune response | | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| GO:0050900 | | leukocyte migration | | The movement of a leukocyte within or between different tissues and organs of the body. |
| GO:0043518 | | negative regulation of DNA damage response, signal transduction by p53 class mediator | | Any process that stops, prevents, or reduces the frequency, rate or extent of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage. |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0090344 | | negative regulation of cell aging | | Any process that decreases the rate, frequency, or extent of cell aging. Cell aging is the progression of the cell from its inception to the end of its lifespan. |
| GO:0071157 | | negative regulation of cell cycle arrest | | Any process that decreases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases. |
| GO:0032269 | | negative regulation of cellular protein metabolic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell. |
| GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:1902166 | | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator. |
| GO:0002906 | | negative regulation of mature B cell apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate, or extent of mature B cell apoptotic process. |
| GO:0033033 | | negative regulation of myeloid cell apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate, or extent of a myeloid cell apoptotic process. |
| GO:0050918 | | positive chemotaxis | | The directed movement of a motile cell or organism towards a higher concentration of a chemical. |
| GO:0030890 | | positive regulation of B cell proliferation | | Any process that activates or increases the rate or extent of B cell proliferation. |
| GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| GO:0043406 | | positive regulation of MAP kinase activity | | Any process that activates or increases the frequency, rate or extent of MAP kinase activity. |
| GO:0090238 | | positive regulation of arachidonic acid secretion | | Any process that increases the rate, frequency, or extent of arachidonic acid secretion, the controlled release of arachidonic acid from a cell or a tissue. |
| GO:2000343 | | positive regulation of chemokine (C-X-C motif) ligand 2 production | | Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production. |
| GO:0050715 | | positive regulation of cytokine secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell. |
| GO:0048146 | | positive regulation of fibroblast proliferation | | Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
| GO:0031666 | | positive regulation of lipopolysaccharide-mediated signaling pathway | | Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide. |
| GO:0061081 | | positive regulation of myeloid leukocyte cytokine production involved in immune response | | Any process that modulates the rate, frequency, or extent of the production of a cytokine that contributes to the immune response. |
| GO:0033138 | | positive regulation of peptidyl-serine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| GO:0042327 | | positive regulation of phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule. |
| GO:0061078 | | positive regulation of prostaglandin secretion involved in immune response | | Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell and contributes to the immune response. |
| GO:0010739 | | positive regulation of protein kinase A signaling | | Any process that increases the rate, frequency, or extent of protein kinase A signaling. PKA signaling is the series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound. |
| GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| GO:0001516 | | prostaglandin biosynthetic process | | The chemical reactions and pathways resulting in the formation of prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring. |
| GO:0070207 | | protein homotrimerization | | The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits. |
| GO:0042127 | | regulation of cell proliferation | | Any process that modulates the frequency, rate or extent of cell proliferation. |
| GO:0043030 | | regulation of macrophage activation | | Any process that modulates the frequency or rate of macrophage activation. |
cellular component |
| GO:0009986 | | cell surface | | The external part of the cell wall and/or plasma membrane. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0043209 | | myelin sheath | | An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0031982 | | vesicle | | Any small, fluid-filled, spherical organelle enclosed by membrane. |